Advertisement

Topics

Fabre-Kramer And Mission Pharmacal Parnter For Antidepressant Tablet Manufacturing

05:15 EST 4 Jan 2018 | Pharmaceutical Processing

Mission will complete the technology transfer to develop and manufacture registration batches of Fabre-Kramer’s novel antidepressant, Travivo (gepirone HCl) Extended Release Tablets.
Contributed Author: 
Fabre-Kramer Pharmaceuticals, Inc.

Original Article: Fabre-Kramer And Mission Pharmacal Parnter For Antidepressant Tablet Manufacturing

NEXT ARTICLE

More From BioPortfolio on "Fabre-Kramer And Mission Pharmacal Parnter For Antidepressant Tablet Manufacturing"

Advertisement
Quick Search
Advertisement
Advertisement